SELAS PHARMACIE DE L'EDEN : revenue, balance sheet and financial ratios

SELAS PHARMACIE DE L'EDEN is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75018), this company of category PME shows in 2022 a revenue of 3.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DE L'EDEN (SIREN 792892911)
Indicator 2023 2022 2019 2018 2016 2015
Revenue N/C 3 589 839 € 2 900 980 € 2 752 043 € 2 482 065 € 2 302 227 €
Net income 200 689 € 325 182 € 255 522 € 218 560 € 198 166 € 195 550 €
EBITDA N/C 452 876 € 359 507 € 291 821 € 291 072 € 316 719 €
Net margin N/C 9.1% 8.8% 7.9% 8.0% 8.5%

Revenue and income statement

In 2023, SELAS PHARMACIE DE L'EDEN generates positive net income of 201 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 196 k€ -> 201 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

200 689 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 88%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

88.246%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

41.343%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

22.3%

Solvency indicators evolution
SELAS PHARMACIE DE L'EDEN

Sector positioning

Debt ratio
88.25 2023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average +6 pts over 3 years

In 2023, the debt ratio of SELAS PHARMACIE DE L'EDEN (88.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
41.34% 2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average -9 pts over 3 years

In 2023, the financial autonomy of SELAS PHARMACIE DE L'EDEN (41.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.22 years 2022
2019
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of SELAS PHARMACIE DE L'EDEN (2.22) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 179.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

179.362

Liquidity indicators evolution
SELAS PHARMACIE DE L'EDEN

Sector positioning

Liquidity ratio
179.36 2023
2019
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average -30 pts over 3 years

In 2023, the liquidity ratio of SELAS PHARMACIE DE L'EDEN (179.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.48x 2022
2019
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average -13 pts over 2 years

In 2022, the interest coverage of SELAS PHARMACIE DE L'EDEN (0.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE DE L'EDEN

Positioning of SELAS PHARMACIE DE L'EDEN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELAS PHARMACIE DE L'EDEN is estimated at 2 368 025 € (range 1 440 109€ - 3 328 911€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
1440k€ 2368k€ 3328k€
2 368 025 € Range: 1 440 109€ - 3 328 911€
NAF 5 année 2023

Valuation method used

Net Income Multiple
200 689 € × 11.8x = 2 368 025 €
Range: 1 440 109€ - 3 328 912€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DE L'EDEN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DE L'EDEN

What is the revenue of SELAS PHARMACIE DE L'EDEN ?

The revenue of SELAS PHARMACIE DE L'EDEN in 2022 is 3.6 M€.

Is SELAS PHARMACIE DE L'EDEN profitable?

Yes, SELAS PHARMACIE DE L'EDEN generated a net profit of 201 k€ in 2023.

Where is the headquarters of SELAS PHARMACIE DE L'EDEN ?

The headquarters of SELAS PHARMACIE DE L'EDEN is located in PARIS (75018), in the department Paris.

Where to find the tax return of SELAS PHARMACIE DE L'EDEN ?

The tax return of SELAS PHARMACIE DE L'EDEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DE L'EDEN operate?

SELAS PHARMACIE DE L'EDEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.